These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16271013)

  • 1. Applications of AmpliChip CYP450.
    Jain KK
    Mol Diagn; 2005; 9(3):119-27. PubMed ID: 16271013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.
    de Leon J; Susce MT; Murray-Carmichael E
    Mol Diagn Ther; 2006; 10(3):135-51. PubMed ID: 16771600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AmpliChip CYP450 test: personalized medicine has arrived in psychiatry.
    de Leon J
    Expert Rev Mol Diagn; 2006 May; 6(3):277-86. PubMed ID: 16706732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study.
    Dodgen TM; Hochfeld WE; Fickl H; Asfaha SM; Durandt C; Rheeder P; Drögemöller BI; Wright GE; Warnich L; Labuschagne CD; van Schalkwyk A; Gaedigk A; Pepper MS
    BMC Med Genet; 2013 Jan; 14():20. PubMed ID: 23356658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA microarray technology in the clinical environment: the AmpliChip CYP450 test for CYP2D6 and CYP2C19 genotyping.
    de Leon J; Susce MT; Johnson M; Hardin M; Maw L; Shao A; Allen AC; Chiafari FA; Hillman G; Nikoloff DM
    CNS Spectr; 2009 Jan; 14(1):19-34. PubMed ID: 19169185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AmpliChip CYP450 GeneChip: a new gene chip that allows rapid and accurate CYP2D6 genotyping.
    Heller T; Kirchheiner J; Armstrong VW; Luthe H; Tzvetkov M; Brockmöller J; Oellerich M
    Ther Drug Monit; 2006 Oct; 28(5):673-7. PubMed ID: 17038884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AmpliChip CYP450 test: principles, challenges, and future clinical utility in digestive disease.
    Juran BD; Egan LJ; Lazaridis KN
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):822-30. PubMed ID: 16797246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
    Johansson I; Ingelman-Sundberg M
    Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a complex CYP2D6 genotype that caused an AmpliChip CYP450 Test no-call in the clinical setting.
    Gaedigk A; Riffel AK; Berrocal BG; Solaesa VG; Dávila I; Isidoro-García M
    Clin Chem Lab Med; 2014 Jun; 52(6):799-807. PubMed ID: 24445243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.
    Rebsamen MC; Desmeules J; Daali Y; Chiappe A; Diemand A; Rey C; Chabert J; Dayer P; Hochstrasser D; Rossier MF
    Pharmacogenomics J; 2009 Feb; 9(1):34-41. PubMed ID: 18591960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of antipsychoatics.
    Ozaki N
    Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 in Pharmacogenetics: An Update.
    Tornio A; Backman JT
    Adv Pharmacol; 2018; 83():3-32. PubMed ID: 29801580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicogenetics--cytochrome P450 microarray analysis in forensic cases focusing on morphine/codeine and diazepam.
    Andresen H; Augustin C; Streichert T
    Int J Legal Med; 2013 Mar; 127(2):395-404. PubMed ID: 22899355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
    Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
    Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and characterization of the CYP2D6*9x2 gene duplication in two Spanish populations: resolution of AmpliChip CYP450 test no-calls.
    Gaedigk A; Hernandez J; García-Solaesa V; Sánchez S; Isidoro-García M
    Pharmacogenomics; 2011 Nov; 12(11):1617-22. PubMed ID: 22044417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics-guided dose modifications of antidepressants.
    Seeringer A; Kirchheiner J
    Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DMET microarray technology for pharmacogenomics-based personalized medicine.
    Burmester JK; Sedova M; Shapero MH; Mansfield E
    Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of a clinical AmpliChip CYP450 Test™ no call: discovery and characterization of novel CYP2D6*1 haplotypes.
    Gaedigk A; Garcia-Ribera C; Jeong HE; Shin JG; Hernandez-Sanchez J
    Pharmacogenomics; 2014 Jun; 15(9):1175-84. PubMed ID: 25141893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.